Little is known about the primary cause of mental illness but in a major area of psychiatry effective secondary prevention has been developed. Potent psychopharmacological agents have become available to the clinical psychiatrist and it has been shown that the prognosis in the psychoses can be significantly improved when continuous drug treatment is prescribed. As treatment has to be given for years the psychiatric clinic has become committed to a potentially large group of patients whose mental wellbeing is dependent upon regular psychotropic medication.
Get full access to this article
View all access options for this article.
References
1.
BaastrupP. C.SchouM. (1967). Lithium as a prophylactic agent: Its effect against recurrent depressions and manic depressive psychosis. Archives of General Psychiatry, 16, 162
2.
CadeJ. F. J. (1949). Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia, 2, 349
HirshS. R.GaindR.RhodeP. D.StevensB. C.WingJ. K. (1973). Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenzine: Double-blind placebo trial. British Medical Journal, 1, 633
5.
HullinR. P.McDonaldR.AllsoppM. N. E. (1972). Prophylactic lithium in recurrent affective disorders. Lancet, 1, 1044